BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

82 related articles for article (PubMed ID: 9796830)

  • 1. The interaction of myristylated peptides with the catalytic domain of protein kinase C revealed by their sequence palindromy and the identification of a myristyl binding site.
    Zaliani A; Pinori M; Ball HL; DiGregorio G; Cremonesi P; Mascagni P
    Protein Eng; 1998 Sep; 11(9):803-10. PubMed ID: 9796830
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Role of N-terminal myristylation in the structure and regulation of cAMP-dependent protein kinase.
    Bastidas AC; Deal MS; Steichen JM; Keshwani MM; Guo Y; Taylor SS
    J Mol Biol; 2012 Sep; 422(2):215-29. PubMed ID: 22617327
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Influence of lipid on the structure and phosphorylation of protein kinase C alpha substrate peptides.
    Vinton BB; Wertz SL; Jacob J; Steere J; Grisham CM; Cafiso DS; Sando JJ
    Biochem J; 1998 Mar; 330 ( Pt 3)(Pt 3):1433-42. PubMed ID: 9494117
    [TBL] [Abstract][Full Text] [Related]  

  • 4. N-myristyl-Lys-Arg-Thr-Leu-Arg: a novel protein kinase C inhibitor.
    O'Brian CA; Ward NE; Liskamp RM; de Bont DB; van Boom JH
    Biochem Pharmacol; 1990 Jan; 39(1):49-57. PubMed ID: 2153382
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification of the calmodulin-binding domain of neuron-specific protein kinase C substrate protein CAP-22/NAP-22. Direct involvement of protein myristoylation in calmodulin-target protein interaction.
    Takasaki A; Hayashi N; Matsubara M; Yamauchi E; Taniguchi H
    J Biol Chem; 1999 Apr; 274(17):11848-53. PubMed ID: 10207003
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibition of T cell activation by protein kinase C pseudosubstrates.
    Barja P; Alavi-Nassab A; Turck CW; Freire-Moar J
    Cell Immunol; 1994 Jan; 153(1):28-38. PubMed ID: 8287492
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Membrane structure of protein kinase C and calmodulin binding domain of myristoylated alanine rich C kinase substrate determined by site-directed spin labeling.
    Qin Z; Cafiso DS
    Biochemistry; 1996 Mar; 35(9):2917-25. PubMed ID: 8608129
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibition of protein kinase C by N-myristoylated peptide substrate analogs.
    Ward NE; O'Brian CA
    Biochemistry; 1993 Nov; 32(44):11903-9. PubMed ID: 8218262
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Rational design of a new C-myristylamido peptide exerting potent and selective PKC inhibitory activity.
    Zaliani A; Gromo G; Pinori M; Mascagni P
    Drug Des Discov; 1996 Apr; 13(3-4):63-74. PubMed ID: 8874044
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibition of protein kinase C catalytic activity by additional regions within the human protein kinase Calpha-regulatory domain lying outside of the pseudosubstrate sequence.
    Kirwan AF; Bibby AC; Mvilongo T; Riedel H; Burke T; Millis SZ; Parissenti AM
    Biochem J; 2003 Jul; 373(Pt 2):571-81. PubMed ID: 12710889
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Influence of myristoylation, phosphorylation, and deamidation on the structural behavior of the N-terminus of the catalytic subunit of cAMP-dependent protein kinase.
    Tholey A; Pipkorn R; Bossemeyer D; Kinzel V; Reed J
    Biochemistry; 2001 Jan; 40(1):225-31. PubMed ID: 11141074
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Altered substrate selectivity of PKC-eta pseudosubstrate site mutants.
    Dekker LV; McIntyre P; Parker PJ
    FEBS Lett; 1993 Aug; 329(1-2):129-33. PubMed ID: 8354386
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Protein kinase C pseudosubstrate prototope: structure-function relationships.
    House C; Kemp BE
    Cell Signal; 1990; 2(2):187-90. PubMed ID: 2400634
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Irreversible inactivation of protein kinase C by a peptide-substrate analog.
    Ward NE; Gravitt KR; O'Brian CA
    J Biol Chem; 1995 Apr; 270(14):8056-60. PubMed ID: 7713907
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Protein kinase C contains a pseudosubstrate prototope in its regulatory domain.
    House C; Kemp BE
    Science; 1987 Dec; 238(4834):1726-8. PubMed ID: 3686012
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Peptides that mimic the pseudosubstrate region of protein kinase C bind to acidic lipids in membranes.
    Mosior M; McLaughlin S
    Biophys J; 1991 Jul; 60(1):149-59. PubMed ID: 1883933
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Substrate specificity of protein kinase C. Use of synthetic peptides corresponding to physiological sites as probes for substrate recognition requirements.
    Woodgett JR; Gould KL; Hunter T
    Eur J Biochem; 1986 Nov; 161(1):177-84. PubMed ID: 3023081
    [TBL] [Abstract][Full Text] [Related]  

  • 18. N-terminal N-myristoylation of proteins: prediction of substrate proteins from amino acid sequence.
    Maurer-Stroh S; Eisenhaber B; Eisenhaber F
    J Mol Biol; 2002 Apr; 317(4):541-57. PubMed ID: 11955008
    [TBL] [Abstract][Full Text] [Related]  

  • 19. N-terminal N-myristoylation of proteins: refinement of the sequence motif and its taxon-specific differences.
    Maurer-Stroh S; Eisenhaber B; Eisenhaber F
    J Mol Biol; 2002 Apr; 317(4):523-40. PubMed ID: 11955007
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Complete activation of protein kinase C by an antipeptide antibody directed against the pseudosubstrate prototope.
    Makowske M; Rosen OM
    J Biol Chem; 1989 Sep; 264(27):16155-9. PubMed ID: 2777783
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.